Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2487780 | Journal of Pharmaceutical Sciences | 2007 | 6 Pages |
Abstract
Due to recent advances in high throughput organic synthesis, discovery teams now need to profile increased numbers of analogs in vitro for their absorption, distribution, metabolism, and excretion (ADME) properties. Consequently, pharmaceutical companies are developing lower cost and higher throughput methods for ADME testing. As demands for metabolic stability testing have increased in our laboratory, the time required to analyze samples using highâpressure liquid chromatographyâmass spectrometry (HPLCâMS) has grown rapidly and ultimately limited our data output. In this study we show that solid phase extractionâmass spectrometry (SPEâMS) is a viable alternative to HPLCâMS for monitoring small molecule stability in liver microsomes. Using the SPEâMS approach, samples can be analyzed in 24Â s compared to 2.5Â min on the HPLCâMS without compromising data quality, thereby alleviating the analytical bottleneck.
Keywords
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Drug Discovery
Authors
Brittany L. Inman, Linda E. Chovan, Peter J. Dandliker, Yau Yi Lau,